Baocheng Chu

Baocheng Chu

Auto-generated profile, based on publicly available information

Baocheng Chu

BioMolecular Imaging Center, Department of Radiology, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2010 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
NBNiranjan Balu
Niranjan Balu
VYVasily L. Yarnykh
Vasily L. Yarnykh
BCBaocheng Chu
Baocheng Chu
JWJinnan Wang
Jinnan Wang
THThomas Hatsukami
Thomas Hatsukami
CYChun Yuan
Chun Yuan
Black‐blood MRI is a promising tool for carotid atherosclerotic plaque burden assessment and compositional analysis. However, current sequences are limited by large slice thickness. Accuracy of measurement can be improved by moving to isotropic imaging but can be challenging for patient compliance due to long scan times. We present a fast isotropic high spatial resolution (0.7 × 0.7 × 0.7 mm3) three‐dimensional black‐blood sequence (3D‐MERGE) covering the entire cervical carotid arteries within 2 min thus ensuring patient compliance and diagnostic image quality. The sequence is optimized for vessel wall imaging of the carotid bifurcation based on its signal properties. The optimized sequence is validated on patients with significant carotid plaque. Quantitative plaque morphology measurements and signal‐to‐noise ratio measures show that 3D‐MERGE provides good blood suppression and comparable plaque burden measurements to existing MRI protocols. 3D‐MERGE is a promising new tool for fast and accurate plaque burden assessment in patients with atherosclerotic plaque. Magn Reson Med, 2011.

1 January 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
DGDuygu Baylam Geleri
Duygu Baylam Geleri
HWHiroko Watase
Hiroko Watase
BCBaocheng Chu
Baocheng Chu
LCLi Chen
Li Chen
Huilin ZhaoHuilin Zhao
Huilin Zhao
OCon behalf of the CARE-II Study Collaborators
on behalf of the CARE-II Study Collaborators
Background and Purpose: Two-dimensional high-resolution multicontrast magnetic resonance imaging (2D-MC MRI) is currently the most reliable and reproducible noninvasive carotid vessel wall imaging technique. However, the long scan time required for 2D-MC MRI restricts its practical clinical application. Alternatively, 3-dimensional motion-sensitized driven-equilibrium prepared rapid gradient echo (3D-MERGE) vessel wall MRI can provide high isotropic resolution with extensive coverage in two minutes. In this study, we sought to prove that 3D-MERGE alone can serve as a screening tool to identify advanced carotid lesions. Methods: Two hundred twenty-seven subjects suspected of recent ischemic stroke or transient ischemic attack were imaged using 2D-MC MRI with an imaging time of 30 minutes, then with 3D-MERGE with an imaging time of 2 minutes, on 3T-MRI scanners. Two experienced reviewers interpreted plaque components using 2D-MC MRI as the reference standard and categorized plaques using a modified American Heart Association lesion classification for MRI. Plaques of American Heart Association type IV and above were classified as advanced. Arteries of American Heart Association types I to II and III were categorized as normal or with early lesions, respectively. One radiologist independently reviewed only 3D-MERGE and labeled the plaques as advanced if they had a wall thickness of >2 mm with high or low signal intensity compared with the adjacent sternocleidomastoid muscle. Sensitivity, specificity, and accuracy for 3D-MERGE were calculated. Results: Four hundred forty-nine arteries from 227 participants (mean age 61.2 years old, 64% male) were included in the analysis. Sensitivity, specificity, and accuracy for identification of advanced lesions on 3D-MERGE were 95.0% (95% CI, 91.8–97.2), 86.9% (95% CI, 81.4–92.0), 93.8% (95% CI, 91.1–95.8), respectively. Conclusions: 3D-MERGE can accurately identify advanced carotid atherosclerotic plaques in patients suspected of stroke or transient ischemic attack. It has a more extensive coverage and higher sensitivity and specificity for advanced plaque detection with a much shorter acquisition time than 2D-MC MRI. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02017756.



13 June 2007
Verified
Book Chapter
Closed access
PDF file
CYChun Yuan
Chun Yuan
WKWilliam Kerwin
William Kerwin
VYVasily L. Yarnykh
Vasily L. Yarnykh
JCJianming Cai
Jianming Cai
MFMarina Ferguson
Marina Ferguson
THThomas Hatsukami
Thomas Hatsukami
Since publication of the First Edition, advances in the diagnosis and prevention and treatment strategies of the vulnerable plaque have necessitated this

19 May 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
NANathaniel Ashford
Nathaniel Ashford
SRSwati Rane
Swati Rane
KFKristen M Farris
Kristen M Farris
JMJasroop Miglani
Jasroop Miglani
BCBaocheng Chu
Baocheng Chu
AHAngela J Hanson
Angela J Hanson
Background: Hypertension and the APOE4 allele are known risk factors for Alzheimer's disease (AD) and E4 carriers show different blood pressure (BP) and cognitive responses to high fat feeding. Objective: We investigated the influence of these factors on global cerebral blood flow (CBF) and four regions of interest (ROIs) (angular gyrus, hippocampus, posterior cingulate, temporal lobe) using arterial spin labeling (ASL) MRI in fasting state and after ingestion of heavy cream in older adults. Methods: 29 adults (age in years 66.8 ± 4.1) underwent baseline and 1, 2, 3-h ASL MRI after ingestion of 100 mL heavy cream. We used pCASL MRI with background suppression to measure CBF in ml/100 g/min. Statistical analyses included mixed-effects modeling and Pearson correlation to ascertain whether CBF changed over time and how variables influenced results. Results: Global CBF decreased at 1-, 2-, and 3-h post-heavy cream, compared to time 0 (overall change 7.11%, p < 0.01); recapitulated in 3 of 4 ROIs. Mean arterial pressure emerged as a predictive variable for both baseline and post-heavy cream CBF (β = −0.25, 95% CI = −0.39, −0.10, p = 0.002). Individuals with higher BP demonstrated reduced CBF, particularly in posterior cingulate and temporal lobe (β = −5.50, 95% CI = −9.9, −1.09; β = −6.28, 95% CI = −12.35, −0.21, respectively, both p < 0.05). Examination of correlations with BP and change scores revealed that this relationship was driven largely by E4 carriers. Conclusions: CBF decreased after ingestion of heavy cream, globally and in regions known to be important in AD, and this finding was driven by E4 carriers with higher BP.